Submit

Login Login

Register Register

Home / Journals / OR / Online First / doi:10.32604/or.2025.070793
Journal Menu
Special Issues
Table of Content

All issues

Online First

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

Past Issues

Open Access

ARTICLE

BHLHE40 Is a Transcriptional Regulatory Target of NFE2L3 in Triple-Negative Breast Cancer

Shail Rakesh Modi, Terrick Andey*, George Acquaah-Mensah*
Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Worcester, MA 01608, USA
* Corresponding Author: Terrick Andey. Email: email; George Acquaah-Mensah. Email: email
(This article belongs to the Special Issue: Identification of potential targets and biomarkers for cancers and the exploration of novel molecular mechanisms of tumorigenesis and metastasis)

Oncology Research https://doi.org/10.32604/or.2025.070793

Received 24 July 2025; Accepted 19 December 2025; Published online 04 January 2026

Abstract

Objectives: The current treatment options and therapeutic targets for triple-negative breast cancer (TNBC), an aggressive subtype of breast cancer (BrCA), are limited. This study aimed to identify novel biomarkers and transcriptional regulatory networks (TRN) inherent in TNBC samples. Methods: We analyzed pan-cancer BrCA datasets from The Cancer Genome Atlas (TCGA) to compare triple-positive breast cancer (TPBC) with TNBC. TRN algorithms and virtual inference of protein-enriched regulon (VIPER) were used to identify master regulators and their target genes. Utilizing TNBC cells (MDA-MB-231 and MDA-MB-468), we validated the relationship of nuclear factor erythroid 2-like 3 (NFE2L3) and basic helix-loop-helix family member E 40 (BHLHE40) by performing a luciferase assay. The expression levels of these targets were measured after transfections with plasmid and siRNA via qRT-PCR and western blots. The effect of these genes on cell proliferation and migration was studied using phenotypic assays. Results: Using computational approaches, we identified NFE2L3 as a master regulator with BHLHE40 as its target gene. NFE2L3 protein binds to the promoter region of BHLHE40 and regulates its transcriptional activity. Additionally, silencing and overexpressing NFE2L3 and BHLHE40 in TNBC cell lines MDA-MB-231 and MDA-MB-468 showed that NFE2L3 directly regulates BHLHE40 at both transcriptional and translational levels. We found that BHLHE40 requires NFE2L3 for cell proliferation and migration in TNBC. Conclusion: These findings underscore the significance of NFE2L3 and BHLHE40 in TNBC, highlighting NFE2L3’s role in regulating the oncogenic activity of BHLHE40 in TNBC cells.

Graphical Abstract

<i>BHLHE40</i> Is a Transcriptional Regulatory Target of <i>NFE2L3</i> in Triple-Negative Breast Cancer

Keywords

Nuclear factor erythroid 2-like 3 (NFE2L3/NRF3); basic helix-loop-helix family member E 40 (BHLHE40/DEC1); triple-negative breast cancer; transcriptional regulatory networks; master regulators

  • 93

    View

  • 11

    Download

  • 0

    Like

Related articles
Copyright© 2026 Tech Science Press
© 1997-2026 TSP (Henderson, USA) unless otherwise stated

Share Link